Medicine and Dentistry
Gallbladder Carcinoma
53%
Neoplasm
13%
Cancer Cell
13%
Methylation
13%
down Regulation
13%
Cancer Survival
13%
Sanger Sequencing
13%
Protein
6%
Carcinoma Cell
6%
In Vitro
6%
Gene Expression
6%
Surgery
6%
Depletion
6%
Enzyme
6%
Somatics
6%
Median Survival Time
6%
Kidney Cancer
6%
Epigenomics
6%
Small Interfering RNA
6%
Bortezomib
6%
Loss of Function Mutation
6%
Drug Sensitivity
6%
Biliary Tract Cancer
6%
Proteasome Inhibitor
6%
Mesothelioma
6%
Uveal Melanoma
6%
Patient
6%
Character
6%
Biliary Duct Cancer
6%
Biochemistry, Genetics and Molecular Biology
BAP1
100%
Cancer Cell
13%
down Regulation
13%
Mutation
13%
Methylation
13%
Gene Mutation
13%
Cancer Survival
13%
Gene Expression
6%
Lysozyme
6%
Proteasome Inhibitor
6%
Small Interfering RNA
6%
Drug Sensitivity
6%
Loss of Function Mutation
6%
Median Survival Time
6%
Epigenomics
6%
In Vitro Study
6%
Protein
6%
Character
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gallbladder Carcinoma
53%
Prognosis
20%
Clinical Study
20%
Neoplasm
13%
Cancer Survival
13%
Enzyme
6%
Protein
6%
Bortezomib
6%
Small Interfering RNA
6%
Median Survival Time
6%
Proteasome Inhibitor
6%
Kidney Cancer
6%
Gallbladder Cancer
6%
Biliary Tract Cancer
6%
Mesothelioma
6%